Dataset from Ranucci M, Sitzia C, Baryshnikova E, Di Dedda U, Cardani R, Martelli F, Corsi Romanelli M. Covid-19-Associated Coagulopathy: Biomarkers of Thrombin Generation and Fibrinolysis Leading the Outcome. J Clin Med. 2020 Oct 28;9(11):3487. doi: 10.3390/jcm9113487. PMID: 33126772; PMCID: PMC7692774.
Creators
- 1. Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, I-20097 San Donato Milanese, Milan, Italy.
- 2. Department of Biomedical Sciences for Health, Chair of Clinical Pathology, University of Milan, I-20133 Milan, Italy.
- 3. Operative Unit of Clinical Pathology SMEL-1, Department of Pathology and Laboratory Medicine, IRCCS Policlinico San Donato, I-20097 San Donato Milanese, Milan, Italy.
- 4. Molecular Cardiology Laboratory, IRCCS Policlinico San Donato, I-20097 San Donato Milanese, Milan, Italy.
- 5. Operative Unit of Clinical Pathology SMEL-1, Department of Pathology and Laboratory
Description
Dataset from the article Ranucci M, Sitzia C, Baryshnikova E, Di Dedda U, Cardani R, Martelli F, Corsi Romanelli M. Covid-19-Associated Coagulopathy: Biomarkers of Thrombin Generation and Fibrinolysis Leading the Outcome. J Clin Med. 2020 Oct 28;9(11):3487. doi: 10.3390/jcm9113487. PMID: 33126772; PMCID: PMC7692774.
Abstract
Background: Coronavirus Disease 2019 (COVID-19)-associated coagulopathy is characterized by a prothrombotic state not yet comprehensively studied. We investigated the coagulation pattern of patients with COVID-19 acute respiratory distress syndrome (ARDS), comparing patients who survived to those who did not. Methods: In this prospective cohort study on 20 COVID-19 ARDS patients, the following biomarkers were measured: thrombin generation (prothrombin fragment 1 + 2 (PF 1 + 2)), fibrinolysis activation (tissue plasminogen activator (tPA)) and inhibition (plasminogen activator inhibitor 2 (PAI-2)), fibrin synthesis (fibrinopeptide A) and fibrinolysis magnitude (plasmin-antiplasmin complex (PAP) and D-dimers). Measurements were done upon intensive care unit (ICU) admission and after 10-14 days. Results: There was increased thrombin generation; modest or null release of t-PA; and increased levels of PAI-2, fibrinopeptide A, PAP and D-dimers. At baseline, nonsurvivors had a significantly (p = 0.014) higher PAI-2/PAP ratio than survivors (109, interquartile range (IQR) 18.1-216, vs. 8.7, IQR 2.9-12.6). At follow-up, thrombin generation was significantly (p = 0.025) reduced in survivors (PF 1 + 2 from 396 pg/mL, IQR 185-585 to 237 pg/mL, IQR 120-393), whereas it increased in nonsurvivors. Fibrinolysis inhibition at follow-up remained stable in survivors and increased in nonsurvivors, leading to a significant (p = 0.026) difference in PAI-2 levels (161 pg/mL, IQR 50-334, vs. 1088 pg/mL, IQR 177-1565). Conclusion: Severe patterns of COVID-19 ARDS are characterized by a thrombin burst and the consequent coagulation activation. Mechanisms of fibrinolysis regulation appear unbalanced toward fibrinolysis inhibition. This pattern ameliorates in survivors, whereas it worsens in nonsurvivors.
Files
Restricted
The record is publicly accessible, but files are restricted to users with access.
Request access
If you would like to request access to these files, please fill out the form below.
You need to satisfy these conditions in order for this request to be accepted:
These data are available upon duly motivated request to the corresponding author of the article
You are currently not logged in. Do you have an account? Log in here